Japan Prepares For Mpox Vaccine Donation

 
• By Lisa Takagi

Manufacturer KM Biologics has confirmed to the Pink Sheet it has filed for an emergency use listing to WHO for its mpox vaccine LC16, which has shown efficacy for post-exposure prophylaxis within 14 days, although its efficacy for pre-exposure prophylaxis is still inconclusive.

Japan's planning to donate mpox vaccine and injector to DRC.
KM Biologics' mpox vaccine approved for prophylactic use in all ages • Source: Shutterstock

More from Middle East & Africa

More from Pink Sheet